To test our hypothesis, we evaluated CDH3 mRNA expression levels by qRT‐PCR in primary GBM samples collected at Hospital de Braga and Hospital de Santa Maria (n = 66; clinical information in Table 1). The gene discussed is CDH3; the disease is glioblastoma.